Ready now,
again
Please google the study. IT doesnt seem like you did
Here is the goal of the study “This study aimed to assess the safety outcome and reported adverse events from hydroxychloroquine use among suspected COVID-19 patients”
They did not look at whether there was benefit from HCQ. That is NOT what the study was looking at. You are confused.
Here is the conclusion
” Conclusion: In our study, results show that the use of hydroxychloroquine for COVID-19 patients in mild to moderate cases in an outpatient setting, within the protocol recommendation and inclusion/exclusion criteria, is safe, highly tolerable, and with minimum side effects”
verbatim.
Again, It did not look as to whether they benefited from HCQ. The study looked at whether it was tolerated. And it showed that it was. Please keep the studies straight.
This has little to do with Dr. Zelnko’s study whre he looked if theire was benefit from HCq/Zinc/Z\azithro And showed there was benefit with hospitalization, but could not show mortality benefit.
tHe Saudi Arabia study looked at whether the treatment was safe/tolerable.
You dont have to read thw whole thing, just read the abstract (sort of a summary)